Identification of functional domains in sarcoglycans essential for their interaction and plasma membrane targeting

Experimental Cell Research

Volumn 312, Issue 9, 2006, Pages 1610-1625

  Chen, Jiwei ^a   Shi, Weixing ^a   Zhang, Yuguang ^a   Sokol, Randi ^b   Cai, Hong ^a   Lun, Mingyue ^a   Moore, Brian F ^a   Farber, Matthew J ^a   Stepanchick, Joel S ^a   Bönnemann, Carsten G ^b   Chan, Yiu mo Michael ^a  

^a WEIS CENTER FOR RESEARCH   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Biotinylation; Dystrophin; Heterologous expression; Immunoprecipitation; Muscular dystrophy; Plasma membrane targeting; Sarcoglycan

Indexed keywords

BETA SARCOGLYCAN; CYSTEINE; DELTA SARCOGLYCAN; DYSTROPHIN; FUNCTIONAL GROUP; GAMMA SARCOGLYCAN; PROTEINASE K; SARCOGLYCAN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; DATA ANALYSIS; EXTRACELLULAR SPACE; IMMUNOPRECIPITATION; MISSENSE MUTATION; MOLECULAR DYNAMICS; MUSCULAR DYSTROPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN STRUCTURE; PROTEIN TARGETING; SENSITIVITY ANALYSIS; STRUCTURE ANALYSIS;

EID: 33646476279     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2006.01.024     Document Type: Article

References (53)

1. Roberds S.L., Leturcq F., Allamand V., Piccolo F., Jeanpierre M., Anderson R.D., Lim L.E., Lee J.C., Tome F.M., and Romero N.B. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell 78 (1994) 625-633
2. Bonnemann C.G., Modi R., Noguchi S., Mizuno Y., Yoshida M., Gussoni E., McNally E.M., Duggan D.J., Angelini C., and Hoffman E.P. Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat. Genet. 11 (1995) 266-273
3. Lim L.E., Duclos F., Broux O., Bourg N., Sunada Y., Allamand V., Meyer J., Richard I., Moomaw C., and Slaughter C. Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat. Genet. 11 (1995) 257-265
4. Noguchi S., McNally E.M., Ben Othmane K., Hagiwara Y., Mizuno Y., Yoshida M., Yamamoto H., Bonnemann C.G., Gussoni E., and Denton P.H. Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science 270 (1995) 819-822
5. Nigro V., de Sa M.E., Piluso G., Vainzof M., Belsito A., Politano L., Puca A.A., Passos-Bueno M.R., and Zatz M. Autosomal recessive limb-girdle muscular dystrophy, LGMD2F, is caused by a mutation in the delta-sarcoglycan gene. Nat. Genet. 14 (1996) 195-198
6. Ettinger A.J., Feng G., and Sanes J.R. epsilon-Sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D. J. Biol. Chem. 272 (1997) 32534-32538
7. Wheeler M.T., Zarnegar S., and McNally E.M. Zeta-sarcoglycan, a novel component of the sarcoglycan complex, is reduced in muscular dystrophy. Hum. Mol. Genet. 11 (2002) 2147-2154
8. Yoshida M., Suzuki A., Yamamoto H., Noguchi S., Mizuno Y., and Ozawa E. Dissociation of the complex of dystrophin and its associated proteins into several unique groups by n-octyl beta-d-glucoside. Eur. J. Biochem. 222 (1994) 1055-1061
9. Shi W., Chen Z., Schottenfeld J., Stahl R.C., Kunkel L.M., and Chan Y.M. Specific assembly pathway of sarcoglycans is dependent on beta- and delta-sarcoglycan. Muscle Nerve 29 (2004) 409-419
10. Holt K.H., and Campbell K.P. Assembly of the sarcoglycan complex. Insights for muscular dystrophy. J. Biol. Chem. 273 (1998) 34667-34670
11. Vainzof M., Passos-Bueno M.R., Canovas M., Moreira E.S., Pavanello R.C., Marie S.K., Anderson L.V., Bonnemann C.G., McNally E.M., Nigro V., Kunkel L.M., and Zatz M. The sarcoglycan complex in the six autosomal recessive limb-girdle muscular dystrophies. Hum. Mol. Genet. 5 (1996) 1963-1969
12. Duggan D.J., Gorospe J.R., Fanin M., Hoffman E.P., and Angelini C. Mutations in the sarcoglycan genes in patients with myopathy. N. Engl. J. Med. 336 (1997) 618-624
13. Koenig M., Hoffman E.P., Bertelson C.J., Monaco A.P., Feener C., and Kunkel L.M. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50 (1987) 509-517
14. Ibraghimov-Beskrovnaya O., Ervasti J.M., Leveille C.J., Slaughter C.A., Sernett S.W., and Campbell K.P. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355 (1992) 696-702
15. Adams M.E., Butler M.H., Dwyer T.M., Peters M.F., Murnane A.A., and Froehner S.C. Two forms of mouse syntrophin, a 58 kd dystrophin-associated protein, differ in primary structure and tissue distribution. Neuron 11 (1993) 531-540
16. Sadoulet-Puccio H.M., Khurana T.S., Cohen J.B., and Kunkel L.M. Cloning and characterization of the human homologue of a dystrophin related phosphoprotein found at the Torpedo electric organ post-synaptic membrane. Hum. Mol. Genet. 5 (1996) 489-496
17. Crosbie R.H., Heighway J., Venzke D.P., Lee J.C., and Campbell K.P. Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex. J. Biol. Chem. 272 (1997) 31221-31224
18. Ervasti J.M., and Campbell K.P. Membrane organization of the dystrophin-glycoprotein complex. Cell 66 (1991) 1121-1131
19. Jung D., Yang B., Meyer J., Chamberlain J.S., and Campbell K.P. Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J. Biol. Chem. 270 (1995) 27305-27310
20. Ahn A.H., and Kunkel L.M. Syntrophin binds to an alternatively spliced exon of dystrophin. J. Cell Biol. 128 (1995) 363-371
21. Sadoulet-Puccio H.M., Rajala M., and Kunkel L.M. Dystrobrevin and dystrophin: an interaction through coiled-coil motifs. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 12413-12418
22. Montanaro F., Lindenbaum M., and Carbonetto S. alpha-Dystroglycan is a laminin receptor involved in extracellular matrix assembly on myotubes and muscle cell viability. J. Cell Biol. 145 (1999) 1325-1340
23. Ervasti J.M., and Campbell K.P. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122 (1993) 809-823
24. Durbeej M., and Campbell K.P. Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr. Opin. Genet. Dev. 12 (2002) 349-361
25. Hack A.A., Cordier L., Shoturma D.I., Lam M.Y., Sweeney H.L., and McNally E.M. Muscle degeneration without mechanical injury in sarcoglycan deficiency. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 10723-10728
26. Betto R., Senter L., Ceoldo S., Tarricone E., Biral D., and Salviati G. Ecto-ATPase activity of alpha-sarcoglycan (adhalin). J. Biol. Chem. 274 (1999) 7907-7912
27. Allikian M.J., Hack A.A., Mewborn S., Mayer U., and McNally E.M. Genetic compensation for sarcoglycan loss by integrin alpha7beta1 in muscle. J. Cell Sci. 117 (2004) 3821-3830
28. Yoshida T., Pan Y., Hanada H., Iwata Y., and Shigekawa M. Bidirectional signaling between sarcoglycans and the integrin adhesion system in cultured L6 myocytes. J. Biol. Chem. 273 (1998) 1583-1590
29. Crosbie R.H., Barresi R., and Campbell K.P. Loss of sarcolemma nNOS in sarcoglycan-deficient muscle. FASEB J. 16 (2002) 1786-1791
30. Lapidos K.A., Kakkar R., and McNally E.M. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ. Res. 94 (2004) 1023-1031
31. Chan Y.M., Bonnemann C.G., Lidov H.G., and Kunkel L.M. Molecular organization of sarcoglycan complex in mouse myotubes in culture. J. Cell Biol. 143 (1998) 2033-2044
32. McNally E.M., Duggan D., Gorospe J.R., Bonnemann C.G., Fanin M., Pegoraro E., Lidov H.G., Noguchi S., Ozawa E., Finkel R.S., Cruse R.P., Angelini C., Kunkel L.M., and Hoffman E.P. Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophy. Hum. Mol. Genet. 5 (1996) 1841-1847
33. Moreira E.S., Vainzof M., Marie S.K., Nigro V., Zatz M., and Passos-Bueno M.R. A first missense mutation in the delta sarcoglycan gene associated with a severe phenotype and frequency of limb-girdle muscular dystrophy type 2F (LGMD2F) in Brazilian sarcoglycanopathies. J. Med. Genet. 35 (1998) 951-953
34. Dincer P., Bonnemann C.G., Erdir A.O., Akcoren Z., Nigro V., Kunkel L.M., and Topalolu H. A homozygous nonsense mutation in delta-sarcoglycan exon 3 in a case of LGMD2F. Neuromuscul. Disord. 10 (2000) 247-250
35. Duggan D.J., Manchester D., Stears K.P., Mathews D.J., Hart C., and Hoffman E.P. Mutations in the delta-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2). Neurogenetics 1 (1997) 49-58
36. Laughery M.D., Todd M.L., and Kaplan J.H. Mutational analysis of alpha-beta subunit interactions in the delivery of Na,K-ATPase heterodimers to the plasma membrane. J. Biol. Chem. 278 (2003) 34794-34803
37. Koenig M., and Kunkel L.M. Detailed analysis of the repeat domain of dystrophin reveals four potential hinge segments that may confer flexibility. J. Biol. Chem. 265 (1990) 4560-4566
38. Miyazaki S., Kuroda Y., and Yokoyama S. Characterization and prediction of linker sequences of multi-domain proteins by a neural network. J. Struct. Funct. Genomics 2 (2002) 37-51
39. Piccolo F., Jeanpierre M., Leturcq F., Dode C., Azibi K., Toutain A., Merlini L., Jarre L., Navarro C., Krishnamoorthy R., Tome F.M., Urtizberea J.A., Beckmann J.S., Campbell K.P., and Kaplan J.C. A founder mutation in the gamma-sarcoglycan gene of gypsies possibly predating their migration out of India. Hum. Mol. Genet. 5 (1996) 2019-2022
40. Nowak K.J., Walsh P., Jacob R.L., Johnsen R.D., Peverall J., McNally E.M., Wilton S.D., Kakulas B.A., and Laing N.G. Severe gamma-sarcoglycanopathy caused by a novel missense mutation and a large deletion. Neuromuscul. Disord. 10 (2000) 100-107
41. van der Kooi A.J., de Visser M., van Meegen M., Ginjaar H.B., van Essen A.J., Jennekens F.G., Jongen P.J., Leschot N.J., and Bolhuis P.A. A novel gamma-sarcoglycan mutation causing childhood onset, slowly progressive limb girdle muscular dystrophy. Neuromuscul. Disord. 8 (1998) 305-308
42. Rafael J.A., Cox G.A., Corrado K., Jung D., Campbell K.P., and Chamberlain J.S. Forced expression of dystrophin deletion constructs reveals structure-function correlations. J. Cell Biol. 134 (1996) 93-102
43. Cox G.A., Sunada Y., Campbell K.P., and Chamberlain J.S. Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Nat. Genet. 8 (1994) 333-339
44. Greenberg D.S., Sunada Y., Campbell K.P., Yaffe D., and Nudel U. Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice. Nat. Genet. 8 (1994) 340-344
45. Helenius A., and Aebi M. Intracellular functions of N-linked glycans. Science 291 (2001) 2364-2369
46. Fernandez-Salas E., Steward L.E., Ho H., Garay P.E., Sun S.W., Gilmore M.A., Ordas J.V., Wang J., Francis J., and Aoki K.R. Plasma membrane localization signals in the light chain of botulinum neurotoxin. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 3208-3213
47. Nilsson I., and von Heijne G. Fine-tuning the topology of a polytopic membrane protein: role of positively and negatively charged amino acids. Cell 62 (1990) 1135-1141
48. Thompson T.G., Chan Y.M., Hack A.A., Brosius M., Rajala M., Lidov H.G., McNally E.M., Watkins S., and Kunkel L.M. Filamin 2 (FLN2): a muscle-specific sarcoglycan interacting protein. J. Cell Biol. 148 (2000) 115-126
49. Grady R.M., Grange R.W., Lau K.S., Maimone M.M., Nichol M.C., Stull J.T., and Sanes J.R. Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat. Cell Biol. 1 (1999) 215-220
50. Lebakken C.S., Venzke D.P., Hrstka R.F., Consolino C.M., Faulkner J.A., Williamson R.A., and Campbell K.P. Sarcospan-deficient mice maintain normal muscle function. Mol. Cell Biol. 20 (2000) 1669-1677
51. Cheng S.H., Gregory R.J., Marshall J., Paul S., Souza D.W., White G.A., O'Riordan C.R., and Smith A.E. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63 (1990) 827-834
52. Anastasi G., Cutroneo G., Trimarchi F., Santoro G., Bruschetta D., Bramanti P., Pisani A., and Favaloro A. Evaluation of sarcoglycans, vinculin-talin-integrin system and filamin2 in alpha- and gamma-sarcoglycanopathy: an immunohistochemical study. Int. J. Mol. Med. 14 (2004) 989-999
53. Leiden Muscular Dystrophy Pages Website, http://www.dmd.nl.